Literature DB >> 27956367

Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.

Jiulong Zhang1, Xiufeng Zhao2, Qing Chen3, Xiaoyi Yin3, Xiu Xin3, Kexin Li3, Mingxi Qiao3, Haiyang Hu3, Dawei Chen3, Xiuli Zhao4.   

Abstract

Multidrug resistance (MDR) of tumor cells is becoming the main reason for the failure of chemotherapy and P-glycoprotein (P-gp) mediated drug efflux has demonstrated to be the key factor for MDR. To address this issue, a novel pH-responsive mixed micelles drug delivery system composed of dextran-g-poly(lactide-co-glycolide)-g-histidine (HDP) and folate acid-D-α-tocopheryl polyethylene glycol 2000 (FA-TPGS2K) copolymers has been designed for the delivery of antitumor agent, paclitaxel (PTX) via FA-receptor mediated cell endocytosis, into PTX-resistant breast cancer MCF-7 cells (MCF-7/PTX). PTX-loaded FA-TPGS2K/HDP mixed micelles were characterized to have a small size distribution, high loading content and excellent pH-responsive drug release profiles. Compared with HDP micelles, FA-TPGS2K/HDP mixed micelles showed a higher cytotoxicity against MCF-7 and MCF-7/PTX cells due to the synergistic effect of FA-receptor mediated cell endocytosis, pH-responsive drug release and TPGS mediated P-gp inhibition. P-gp expression level, ATP content and mitochondrial membrane potential change have been measured, the results indicated blank FA-TPGS2K/HDP mixed micelles could inhibit the P-gp activity by reducing the mitochondrial membrane potential and depleting ATP content but not down-regulating the P-gp expression. In vivo antitumor activities demonstrated FA-TPGS2K/HDP mixed micelles could reach higher antitumor activity compared with HDP micelles for MCF-7/PTX tumor cells. Histological assay also indicated that FA-TPGS2K/HDP mixed micelles showed strongly apoptosis inducing effect, anti-proliferation effect and anti-angiogenesis effect. All these evidences demonstrated this pH-sensitive FA-TPGS2K/HDP micelle-based drug delivery system is a promising approach for overcoming MDR. STATEMENT OF SIGNIFICANCE: In this work, a novel FA-TPGS2K copolymer has been synthesized and used it to construct mixed micelles with HDP copolymer to overcome MDR effect. Furthermore, a series in vitro and in vivo evaluations have been made, which supported enough evidences for the efficient delivery of antitumor drug to MDR cells.
Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multidrug resistance (MDR); Polymeric micelles; Systematic evaluation; pH-Sensitive

Mesh:

Substances:

Year:  2016        PMID: 27956367     DOI: 10.1016/j.actbio.2016.12.021

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  10 in total

1.  Novel pH-Sensitive Urushiol-Loaded Polymeric Micelles for Enhanced Anticancer Activity.

Authors:  Hao Zhou; Chengzhang Wang; Zhiwen Qi; Xingying Xue
Journal:  Int J Nanomedicine       Date:  2020-05-29

2.  Two-Pronged Anti-Tumor Therapy by a New Polymer-Paclitaxel Conjugate Micelle with an Anti-Multidrug Resistance Effect.

Authors:  Juan Du; Lanlan Zong; Mengmeng Li; Keke Yu; Yonghui Qiao; Qi Yuan; Xiaohui Pu
Journal:  Int J Nanomedicine       Date:  2022-03-22

3.  Doxorubicin-Loaded Carbon Dots Lipid-Coated Calcium Phosphate Nanoparticles for Visual Targeted Delivery and Therapy of Tumor.

Authors:  Jian Zhang; Hongyan Zhang; Jianqi Jiang; Nan Cui; Xiao Xue; Tianying Wang; Xiaoqiang Wang; Yunpeng He; Dongkai Wang
Journal:  Int J Nanomedicine       Date:  2020-01-21

4.  Dual Receptor-Targeted and Redox-Sensitive Polymeric Micelles Self-Assembled from a Folic Acid-Hyaluronic Acid-SS-Vitamin E Succinate Polymer for Precise Cancer Therapy.

Authors:  Yue Yang; Yunjian Li; Kai Chen; Ling Zhang; Sen Qiao; Guoxin Tan; Fen Chen; Weisan Pan
Journal:  Int J Nanomedicine       Date:  2020-04-24

5.  Polymeric mixed micelles loaded mitoxantrone for overcoming multidrug resistance in breast cancer via photodynamic therapy.

Authors:  Zeyong Li; Yuee Cai; Yiqiao Zhao; Hua Yu; Haiyu Zhou; Meiwan Chen
Journal:  Int J Nanomedicine       Date:  2017-09-06

6.  pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery.

Authors:  Menghao Shi; Xiufeng Zhao; Jiulong Zhang; Shuang Pan; Chunrong Yang; Ying Wei; Haiyang Hu; Mingxi Qiao; Dawei Chen; Xiuli Zhao
Journal:  Int J Nanomedicine       Date:  2018-10-26

7.  A Smart pH-Sensitive Delivery System for Enhanced Anticancer Efficacy via Paclitaxel Endosomal Escape.

Authors:  Yihua Yang; Zhe Wang; Ying Peng; Jinsong Ding; Wenhu Zhou
Journal:  Front Pharmacol       Date:  2019-01-24       Impact factor: 5.810

8.  A siramesine-loaded metal organic framework nanoplatform for overcoming multidrug resistance with efficient cancer cell targeting.

Authors:  Jiahui Liu; Menghuan Tang; Yanghao Zhou; Yijuan Long; Yuan Cheng; Huzhi Zheng
Journal:  RSC Adv       Date:  2020-02-14       Impact factor: 3.361

Review 9.  Strategies and Mechanism in Reversing Intestinal Drug Efflux in Oral Drug Delivery.

Authors:  Rong Lu; Yun Zhou; Jinqian Ma; Yuchen Wang; Xiaoqing Miao
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

10.  Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes.

Authors:  Menghao Shi; Jiulong Zhang; Xiaowei Li; Shuang Pan; Jie Li; Chunrong Yang; Haiyang Hu; Mingxi Qiao; Dawei Chen; Xiuli Zhao
Journal:  Int J Nanomedicine       Date:  2018-07-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.